Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
about
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.Whole-body and hepatic insulin resistance in obese childrenPathophysiology of diabetic dyslipidaemia: where are we?Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese IndividualsFasting enriches liver triacylglycerol with n-3 polyunsaturated fatty acids: implications for understanding the adipose-liver axis in serum docosahexaenoic acid regulationInfluence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver DiseaseSerum TAG analysis differentiates between genetic and obesity-associated NAFLDThe intersection of nonalcoholic fatty liver disease and obesity.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.NAFLD risk alleles in PNPLA3, TM6SF2, GCKR, and LYPLAL1 show divergent metabolic effects.rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver diseaseReplyDissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation
P2860
Q34110246-DA423E63-DEE2-45F7-A14F-0E9ED7132B02Q34550127-75327796-E6D4-4F1B-BCAB-7C49D12EB6DBQ35350326-E7830E36-73D5-4A62-9B26-B40ED208A778Q35704998-0F07E363-EC6E-42DD-B0BE-1F1D1821A73FQ35814800-5B9EBFDE-5D8D-43AC-B96D-22E8EE138B9BQ36074470-6D40144E-108F-4E1F-9035-C9F46C482E57Q36118420-E744947A-8E33-45FE-8D82-539BB18F8EF7Q36126574-4424E6FE-9C7D-4063-8023-0C9E3E5B93A1Q37670156-AB13976F-6045-48F6-835F-CCDFFD1F314AQ38714560-DD1490CB-9132-4FDE-A2AF-85D49FAFCBD4Q38833111-D31BDC07-0A59-43A6-835F-48E66A98F52EQ38859044-6D47E3F2-C2BB-4DDE-9763-8F4A0DD39A94Q39487830-E475DE2E-48D1-4CD9-8525-2CA0A1DB5E0DQ40108180-40291BD7-0EEE-4A96-8D08-4337989747B8Q41449920-ED79E4AD-75BB-4084-95E2-D071CF9B519EQ42153080-D7662996-94EC-4A82-BF7E-FF7DBDCB134DQ46809561-9FF773B7-3E0E-45BF-AA0B-7D33D4C2E547Q52323790-BF3E1C19-4BE4-4A06-9400-509AB546161DQ57069563-D8B1FF8E-7C0C-46C9-B1CC-93BC3EDBAD70Q57659790-C99F63C7-E085-477E-B833-89309162E057Q58729926-CC2E2682-381C-481A-87CA-E17784F9E5C8
P2860
Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Circulating triacylglycerol si ...... nt in PNPLA3 and with obesity.
@en
Circulating triacylglycerol si ...... nt in PNPLA3 and with obesity.
@nl
type
label
Circulating triacylglycerol si ...... nt in PNPLA3 and with obesity.
@en
Circulating triacylglycerol si ...... nt in PNPLA3 and with obesity.
@nl
prefLabel
Circulating triacylglycerol si ...... nt in PNPLA3 and with obesity.
@en
Circulating triacylglycerol si ...... nt in PNPLA3 and with obesity.
@nl
P2093
P50
P356
P1433
P1476
Circulating triacylglycerol si ...... nt in PNPLA3 and with obesity.
@en
P2093
Anne Juuti
Jenni Hyysalo
Marja Leivonen
Nabil Jaser
Pirjo Nuutila
Tuulia Hyötyläinen
P304
P356
10.2337/DB13-0774
P407
P577
2013-09-05T00:00:00Z